Ubs Group Ag Red Hill Biopharma Ltd. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$0.14 - $695.9 $588 - $2.93 Million
-4,206 Reduced 59.26%
2,891 $0
Q3 2022

Nov 10, 2022
SELL
$0.5 - $523.8 $5,930 - $6.21 Million
-11,860 Reduced 62.56%
7,097 $3,000
Q2 2022

Aug 10, 2022
BUY
$0.63 - $2.58 $927 - $3,800
1,473 Added 8.42%
18,957 $17,000
Q1 2022

May 16, 2022
SELL
$1.65 - $3.12 $368,557 - $696,908
-223,368 Reduced 92.74%
17,484 $44,000
Q4 2021

Feb 14, 2022
BUY
$2.31 - $5.85 $323,513 - $819,286
140,049 Added 138.93%
240,852 $622,000
Q3 2021

Nov 15, 2021
BUY
$4.55 - $10.36 $31,854 - $72,530
7,001 Added 7.46%
100,803 $462,000
Q2 2021

Aug 13, 2021
BUY
$5.98 - $7.51 $327,410 - $411,180
54,751 Added 140.2%
93,802 $645,000
Q1 2021

May 12, 2021
SELL
$6.98 - $11.29 $74,337 - $120,238
-10,650 Reduced 21.43%
39,051 $286,000
Q4 2020

Feb 11, 2021
BUY
$7.81 - $10.39 $345,959 - $460,245
44,297 Added 819.71%
49,701 $401,000
Q3 2020

Nov 12, 2020
BUY
$6.34 - $10.83 $19,102 - $32,630
3,013 Added 126.01%
5,404 $55,000
Q3 2019

Nov 14, 2019
SELL
$6.46 - $8.37 $6,621 - $8,579
-1,025 Reduced 30.01%
2,391 $17,000
Q2 2019

Aug 14, 2019
SELL
$6.34 - $8.8 $9,611 - $13,340
-1,516 Reduced 30.74%
3,416 $23,000
Q1 2019

May 14, 2019
BUY
$6.06 - $9.0 $15,398 - $22,869
2,541 Added 106.27%
4,932 $41,000
Q4 2018

Feb 14, 2019
SELL
$5.18 - $9.35 $23,786 - $42,935
-4,592 Reduced 65.76%
2,391 $13,000
Q3 2018

Nov 14, 2018
BUY
$6.0 - $11.35 $23,430 - $44,321
3,905 Added 126.87%
6,983 $62,000
Q2 2018

Aug 14, 2018
BUY
$4.82 - $8.53 $1,720 - $3,045
357 Added 13.12%
3,078 $26,000
Q1 2018

May 15, 2018
BUY
$4.96 - $6.84 $3,576 - $4,931
721 Added 36.05%
2,721 $14,000
Q3 2017

Nov 14, 2017
SELL
$8.25 - $10.81 $1,542 - $2,021
-187 Reduced 8.55%
2,000 $22,000
Q2 2017

Aug 14, 2017
SELL
N/A
-1,996 Reduced 47.72%
2,187 $19,000
Q1 2017

Nov 14, 2017
BUY
N/A
4,183
4,183 $40,000

Others Institutions Holding RDHL

# of Institutions
2
Shares Held
40.4K
Call Options Held
0
Put Options Held
0
View Full List

About RedHill Biopharma Ltd.

RDHL Quotes by TradingView
  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $465M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email